Kliewer Steven A
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8594, USA.
J Nutr. 2003 Jul;133(7 Suppl):2444S-2447S. doi: 10.1093/jn/133.7.2444S.
The pregnane X receptor (PXR), which is a member of the nuclear receptor family of ligand-activated transcription factors, is an integral component of the body's defense mechanism against toxic xenobiotics. PXR is activated by a broad spectrum of lipophilic xenobiotics including prescription drugs, herbs, pesticides, endocrine disruptors and other environmental contaminants. The promiscuous ligand-binding properties of PXR are facilitated by the large volume and smooth shape of its ligand-binding pocket. PXR binds to DNA as a heterodimer with the 9-cis retinoic acid receptor (RXR) and regulates a large number of genes involved in the detoxification and excretion of toxic substances. Although PXR evolved to protect the body, its activation by various prescription drugs and herbs such as St. John's wort represents the molecular basis for an important class of drug-drug interactions. Assays that detect PXR activation can now be used to predict and prevent these drug-drug interactions.
孕烷X受体(PXR)是配体激活转录因子核受体家族的成员,是机体抵御有毒外源性物质防御机制的重要组成部分。PXR可被包括处方药、草药、杀虫剂、内分泌干扰物及其他环境污染物在内的多种亲脂性外源性物质激活。PXR配体结合口袋体积大且形状平滑,有助于其具有广泛的配体结合特性。PXR作为异源二聚体与9-顺式维甲酸受体(RXR)结合于DNA,并调控大量参与有毒物质解毒和排泄的基因。尽管PXR的进化是为了保护机体,但其被各种处方药和草药(如圣约翰草)激活却是一类重要药物相互作用的分子基础。现在,检测PXR激活的分析方法可用于预测和预防这些药物相互作用。